Abstract
Hollow core/shell carbon microparticles, denoted HCSC600, are synthesized from yeast cells by coating the cells with silica shells, and then pyrolyzing the silica-protected yeast cells at 600°C, and finally etching the silica shells off of the carbonized products. The microparticles possess a yolk/shell structure with very large interior hollow spaces and interconnected porous structures-structural features that are generally useful for adsorption and release of drug molecules. The microparticles are characterized by various methods, including scanning electron microscopy, transmission electron microscopy, nitrogen gas adsorption/desorption and X-ray photoelectron spectroscopy. Their adsorption properties are evaluated by using rhodamine B (RhB) as a model drug and the poorly soluble drug fenofibrate (FFB), a prodrug of fenofibric acid, which is widely used to treat hypertriglyceridemia. Compared with the control material prepared from yeast cells without silica coating (named YCC600), the HCSC microparticles showed much higher adsorption capacity for both compounds, suggesting that the silica coating is important not only for controlling the morphology of the particles but also for giving them high surface area. Furthermore, it is found that the HCSC600 material loaded with FFB allows the drug molecules to be released faster and better than they are from the bulk drug. The results indicate that HCSC microparticles have great potential to serve as drug delivery vehicles, especially for poorly bioavailable drugs such as FFB, for biomedical applications.
| Original language | English |
|---|---|
| Pages (from-to) | 30226-30233 |
| Number of pages | 8 |
| Journal | RSC Advances |
| Volume | 6 |
| Issue number | 36 |
| DOIs | |
| Publication status | Published - Jan 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Chemistry(all)
- Chemical Engineering(all)
Cite this
Improving the dissolution of fenofibrate with yeast cell-derived hollow core/shell carbon microparticles. / Huang, Xiaoxi; Zhang, Tao; Zou, Xiaoxin; Tao, Zhimin; Asefa, Teddy.
In: RSC Advances, Vol. 6, No. 36, 01.01.2016, p. 30226-30233.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Improving the dissolution of fenofibrate with yeast cell-derived hollow core/shell carbon microparticles
AU - Huang, Xiaoxi
AU - Zhang, Tao
AU - Zou, Xiaoxin
AU - Tao, Zhimin
AU - Asefa, Teddy
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Hollow core/shell carbon microparticles, denoted HCSC600, are synthesized from yeast cells by coating the cells with silica shells, and then pyrolyzing the silica-protected yeast cells at 600°C, and finally etching the silica shells off of the carbonized products. The microparticles possess a yolk/shell structure with very large interior hollow spaces and interconnected porous structures-structural features that are generally useful for adsorption and release of drug molecules. The microparticles are characterized by various methods, including scanning electron microscopy, transmission electron microscopy, nitrogen gas adsorption/desorption and X-ray photoelectron spectroscopy. Their adsorption properties are evaluated by using rhodamine B (RhB) as a model drug and the poorly soluble drug fenofibrate (FFB), a prodrug of fenofibric acid, which is widely used to treat hypertriglyceridemia. Compared with the control material prepared from yeast cells without silica coating (named YCC600), the HCSC microparticles showed much higher adsorption capacity for both compounds, suggesting that the silica coating is important not only for controlling the morphology of the particles but also for giving them high surface area. Furthermore, it is found that the HCSC600 material loaded with FFB allows the drug molecules to be released faster and better than they are from the bulk drug. The results indicate that HCSC microparticles have great potential to serve as drug delivery vehicles, especially for poorly bioavailable drugs such as FFB, for biomedical applications.
AB - Hollow core/shell carbon microparticles, denoted HCSC600, are synthesized from yeast cells by coating the cells with silica shells, and then pyrolyzing the silica-protected yeast cells at 600°C, and finally etching the silica shells off of the carbonized products. The microparticles possess a yolk/shell structure with very large interior hollow spaces and interconnected porous structures-structural features that are generally useful for adsorption and release of drug molecules. The microparticles are characterized by various methods, including scanning electron microscopy, transmission electron microscopy, nitrogen gas adsorption/desorption and X-ray photoelectron spectroscopy. Their adsorption properties are evaluated by using rhodamine B (RhB) as a model drug and the poorly soluble drug fenofibrate (FFB), a prodrug of fenofibric acid, which is widely used to treat hypertriglyceridemia. Compared with the control material prepared from yeast cells without silica coating (named YCC600), the HCSC microparticles showed much higher adsorption capacity for both compounds, suggesting that the silica coating is important not only for controlling the morphology of the particles but also for giving them high surface area. Furthermore, it is found that the HCSC600 material loaded with FFB allows the drug molecules to be released faster and better than they are from the bulk drug. The results indicate that HCSC microparticles have great potential to serve as drug delivery vehicles, especially for poorly bioavailable drugs such as FFB, for biomedical applications.
UR - http://www.scopus.com/inward/record.url?scp=85022145047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85022145047&partnerID=8YFLogxK
U2 - 10.1039/c6ra00308g
DO - 10.1039/c6ra00308g
M3 - Article
AN - SCOPUS:85022145047
VL - 6
SP - 30226
EP - 30233
JO - RSC Advances
JF - RSC Advances
SN - 2046-2069
IS - 36
ER -